Teva Pharmaceutical Industries (NYSE:TEVA) Settles Class-Action Lawsuit For US$2 Million
Teva Pharmaceutical Industries recently made headlines by agreeing to a $2.25 million settlement in a class-action lawsuit concerning Effexor XR®. This legal development, although not directly affecting the physical trading…
%20Settles%20Class-Action%20Lawsuit%20For%20US$2%20Million){kind=link}